I initially came across Mesoscale when looking at Quanterix. Like Quanterix, Mesoscale make very high sensitivity claims for their immunoassay, in the fg/ml range. Mesoscale Diagnostics has also been around for much longer that Quanterix having been founded in 1995. They are rep…
Somalogic are developing a aptamer based protein detection platform with a microarray-like readout. Aptamers have been around since the 1990s, the basi…
Earlier this week I wrote up my initial observations and thoughts on Quanterix. In this post I’m going to briefly cover a few further observations and …
Quanterix was formed in 2007 with a focus on building a “single molecule” detection platform with a focus on proteomics applications. They raised a tot…
Olink is developing a novel sequencing based proteomics platform. Their 2020 revenue was $54.1 million, 16.7% growth on 2019. This year growth looks se…
So Illumina are pushing forward with their GRAIL acquisition. It seems like a good time to review what (little) I know of the early stage cancer detect…
I was recently asked about Nooma Bio. This is a company and approach I’ve not looked at for some time. But it appears they published a couple of papers…
Solexa has come up in a few conversations recently. Obviously Solexa’s contribution to next-gen sequencing is difficult to ignore. But it’s also an int…
See all